Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7005437rdf:typepubmed:Citationlld:pubmed
pubmed-article:7005437lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7005437lifeskim:mentionsumls-concept:C0029974lld:lifeskim
pubmed-article:7005437lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:7005437pubmed:issue1lld:pubmed
pubmed-article:7005437pubmed:dateCreated1981-3-24lld:pubmed
pubmed-article:7005437pubmed:abstractTextRabbit antiserum raised against isolated human ova produced an intense immunofluorescence and a precipitate on the outer surface of human and porcine zonae pellucidae. The antiserum reacted with none of 22 human tissues nor with any of 4 body fluid components by immunofluorescence or immunodiffusion analysis, but the antiserum agglutinated AB erythrocytes after absorption with O erythrocytes. The anti-zona activity was achieved by higher titres for human than for porcine zonae. Immunofluorescence on porcine zonae was completely abolished by absorption with porcine ova, whereas a weak but definite fluorescence remained on human zonae. These findings indicate that the human zona pellucida consists of at least three distinct components; (1) a specific antigen(s) shared by human and porcine zonae, (2) an antigen(s) specific to human zonae, and (3) a non-specific antigen(s) associated with the blood group substances.lld:pubmed
pubmed-article:7005437pubmed:languageenglld:pubmed
pubmed-article:7005437pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7005437pubmed:citationSubsetIMlld:pubmed
pubmed-article:7005437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7005437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7005437pubmed:statusMEDLINElld:pubmed
pubmed-article:7005437pubmed:monthJanlld:pubmed
pubmed-article:7005437pubmed:issn0022-4251lld:pubmed
pubmed-article:7005437pubmed:authorpubmed-author:MoriTTlld:pubmed
pubmed-article:7005437pubmed:authorpubmed-author:NodaYYlld:pubmed
pubmed-article:7005437pubmed:authorpubmed-author:NishimuraTTlld:pubmed
pubmed-article:7005437pubmed:authorpubmed-author:TakaiIIlld:pubmed
pubmed-article:7005437pubmed:issnTypePrintlld:pubmed
pubmed-article:7005437pubmed:volume61lld:pubmed
pubmed-article:7005437pubmed:ownerNLMlld:pubmed
pubmed-article:7005437pubmed:authorsCompleteYlld:pubmed
pubmed-article:7005437pubmed:pagination19-24lld:pubmed
pubmed-article:7005437pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:meshHeadingpubmed-meshheading:7005437-...lld:pubmed
pubmed-article:7005437pubmed:year1981lld:pubmed
pubmed-article:7005437pubmed:articleTitleHeteroimmunization with isolated human ova.lld:pubmed
pubmed-article:7005437pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7005437pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7005437lld:pubmed